# Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections

> **NCT04763759** · PHASE1 · COMPLETED · sponsor: **Trellis Bioscience LLC** · enrollment: 15 (actual)

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **DRUG:** TRL1068, a human monoclonal antibody

## Key facts

- **NCT ID:** NCT04763759
- **Lead sponsor:** Trellis Bioscience LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2024-03-13
- **Final completion:** 2024-03-13
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763759, "Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04763759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*